Elite Pharma Stock Analysis
| ELTP Stock | USD 0.42 0.02 4.55% |
Elite Pharma holds a debt-to-equity ratio of 0.573. Elite Pharma's financial risk is the risk to Elite Pharma stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Elite Pharma's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Elite Pharma's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the OTC Stock is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Elite OTC Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Elite Pharma's stakeholders.
For many companies, including Elite Pharma, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Elite Pharma, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Elite Pharma's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Elite Pharma's debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Elite Pharma is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Elite Pharma to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Elite Pharma is said to be less leveraged. If creditors hold a majority of Elite Pharma's assets, the OTC Stock is said to be highly leveraged.
Elite Pharma is fairly valued with Real Value of 0.41 and Hype Value of 0.42. The main objective of Elite Pharma otc analysis is to determine its intrinsic value, which is an estimate of what Elite Pharma is worth, separate from its market price. There are two main types of Elite Pharma's stock analysis: fundamental analysis and technical analysis.
The Elite Pharma otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Elite |
Elite OTC Stock Analysis Notes
About 18.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.12. Some equities with similar Price to Book (P/B) outperform the market in the long run. Elite Pharma had not issued any dividends in recent years. Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey. Elite Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 43 people.The quote for Elite Pharma is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about Elite Pharma call Nasrat Hakim at 201 750 2646 or check out https://www.elitepharma.com.Elite Pharma Investment Alerts
| Elite Pharma generated a negative expected return over the last 90 days | |
| Elite Pharma has some characteristics of a very speculative penny stock | |
| Elite Pharma has high historical volatility and very poor performance | |
| About 18.0% of the company shares are held by company insiders |
Elite Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 38.53 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Elite Pharma's market, we take the total number of its shares issued and multiply it by Elite Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Elite Profitablity
Elite Pharma's profitability indicators refer to fundamental financial ratios that showcase Elite Pharma's ability to generate income relative to its revenue or operating costs. If, let's say, Elite Pharma is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Elite Pharma's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Elite Pharma's profitability requires more research than a typical breakdown of Elite Pharma's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15. Technical Drivers
As of the 2nd of February, Elite Pharma shows the Standard Deviation of 3.21, mean deviation of 2.23, and Variance of 10.3. Elite Pharma technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Elite Pharma, which can be compared to its peers.Elite Pharma Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Elite Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Elite Pharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Elite Pharma Predictive Daily Indicators
Elite Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Elite Pharma otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Elite Pharma Forecast Models
Elite Pharma's time-series forecasting models are one of many Elite Pharma's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Elite Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Elite Pharma Debt to Cash Allocation
Elite Pharma currently holds 1.39 M in liabilities with Debt to Equity (D/E) ratio of 0.57, which is about average as compared to similar companies. Elite Pharma has a current ratio of 4.41, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Elite Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Elite Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Elite Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Elite to invest in growth at high rates of return. When we think about Elite Pharma's use of debt, we should always consider it together with cash and equity.Elite Pharma Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Elite Pharma's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Elite Pharma, which in turn will lower the firm's financial flexibility.About Elite OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Elite Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Elite shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Elite Pharma. By using and applying Elite OTC Stock analysis, traders can create a robust methodology for identifying Elite entry and exit points for their positions.
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey. Elite Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 43 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Elite Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Additional Tools for Elite OTC Stock Analysis
When running Elite Pharma's price analysis, check to measure Elite Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elite Pharma is operating at the current time. Most of Elite Pharma's value examination focuses on studying past and present price action to predict the probability of Elite Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elite Pharma's price. Additionally, you may evaluate how the addition of Elite Pharma to your portfolios can decrease your overall portfolio volatility.